Warnings
Ketamine (33%); MDMA (14%); Caffeine (30%); Procaine (10%); 2C-B (1%); Unknown (12%)
Greint Ketamín 33%, MDMA 14%, Koffín 30%, Prókaín 10%, 2C-B 1%, Unknown 12%. Staðsetning: Marseille, Frakkland. Dagsetning: 2025-11-20. Uppruni: druglab.fr.
Ketamine (33%); MDMA (14%); Caffeine (30%); Procaine (10%); 2C-B (1%); Unknown (12%)-pilla — Marseille, Frakkland — 2025-11-20
- Detected
- Ketamine 33%, MDMA 14%, Caffeine 30%, Procaine 10%, 2C-B 1%, Unknown 12%
- Expected
- Unknown
- Logo
- Unknown
- Color
- pink
- Location
- Marseille, France
- Date
- 2025-11-20
- Source
- druglab.fr
- Media
- 1 image
Appearance
- Color: pink
- Media: 1 sample photo
Detected Substances
- Ketamine 33%
- MDMA 14%
- Caffeine 30%
- Procaine 10%
- 2C-B 1%
- Unknown 12%
Expected vs Detected
No expected substance was recorded for this sample.
Detected result: Ketamine 33%, MDMA 14%, Caffeine 30%, Procaine 10%, 2C-B 1%, Unknown 12%
Sample Details
No additional sample descriptors available.
Testing Context
- Location: Marseille, Frakkland
- Date tested: 2025-11-20
- Source: druglab.fr
Harm Reduction
- Similar-looking pills can contain different substances or strengths.
- Use drug checking services when available.
- Start low and avoid assuming a logo identifies the contents.
SampleDNA Beta
22182 tengdar viðvaranir · Kynntu þér algeng óhreinindi.
- Ketamine33%
- MDMA14%
- Caffeine30%
- Procaine10%
- 2C-B1%
- Unknown12%
Tengd sýni og samsetningar
2C-B + Caffeine + Ketamine + MDMA + Procaine
2 sýni
Greind saman í tengdum niðurstöðum efnagreiningar.
2C-B + 4-BMC + Caffeine + Ketamine + MDMA + Unknown
1 sýni
Greind saman í tengdum niðurstöðum efnagreiningar.
2C-B + Caffeine + Ketamine + MDMA + Unknown
1 sýni
Greind saman í tengdum niðurstöðum efnagreiningar.
2C-B + Caffeine + Ketamine + MDMA
9 sýni
Greind saman í tengdum niðurstöðum efnagreiningar.
Caffeine + Ketamine + MDMA + Procaine
2 sýni
Greind saman í tengdum niðurstöðum efnagreiningar.
SampleDNA skoðari
Links
This static page is intended as the readable export baseline for crawler and low-capability delivery.